After Superman and Peacemaker season 2, the DCU will expand with a new live-action take on the Green Lanterns for HBO. In brightest day, in blackest night, no property shall escape DC Studios' sight.

Solar lanterns add the most eco-friendly, adorable lighting to any outdoor space. You can line pathways, hedges, your patio and more using solar-powered lanterns. Solar langerns are super ...

Despite taking place on Earth, and therefore less “cosmic” than the comics, the upcoming Lanterns series for HBO, based on DC’s Green Lantern mythology, already has several characters from ...

“We have the coldest beer in downtown Naperville,” Lococo said. This mural on the side of The Lantern welcomes visitors to downtown Naperville and the iconic watering hole that’s been there ...

Following his stint as Gardner in Superman, Fillion will reprise the role in Peacemaker Season 2 and Lanterns. Fillion has previously spoken about Gardner and referred to him as a “jerk,” just ...

Antaan’s character description sounds like Atros, a.k.a. the raging Red Lantern Atrocitus. The villain debuted in the pages of Geoff Johns and Ethan Van Sciver’s Green Lantern #25 in 2007 ...

From the darkness, in his Lantern attire and carrying a lit torch, emerged the fan favorite Green Lantern G’nort. He was quite excited to see the trio, as he says he hasn’t seen a friendly ...

This is "Green Lantern: Fractured Spectrum" Issue 1 by Jeremy Adams. A new chapter in the Green Lantern saga begins today with the return of the Green Lantern Corps and the arrival of the new ...

We found a lantern on sale right now that is great for any emergency situation or camping, no charging required. The Dynamo Hand Crank Solar Powered Lantern, originally $44, is now just $13 at Amazon.

Lanterns is one of the big shows that will be part of the first phase of James Gunn and Peter Safran’s new DCU (which is officially called Gods and Monsters: Chapter One), and it’s being ...

The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 ...